Apigenin, by activating p53 and inhibiting STAT3, modulates the balance between pro-apoptotic and pro-survival pathways to induce PEL cell death
Crossref DOI link: https://doi.org/10.1186/s13046-017-0632-z
Published Online: 2017-11-28
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Granato, Marisa
Gilardini Montani, Maria Saveria
Santarelli, Roberta
D’Orazi, Gabriella
Faggioni, Alberto
Cirone, Mara